| Expression pattern: |
DN |
| Associated gene: |
ALX4 |
| Associated microRNA: |
miR-1204 |
| Biological function: |
circKLHL24 suppresses breast cancer cell viability, colony formation, migration, invasion, glycolysis metabolism, and tumor growth in vivo. |
| Molecular mechanism: |
circKLHL24 acts as a competing endogenous RNA sponge for miR-1204, thereby upregulating ALX4 and inhibiting breast cancer progression. |
| Biological pathway or process: |
proliferation (inhibits); migration (inhibits); invasion (inhibits); glycolysis (inhibits); ceRNA regulation (other) |
| Detected method: |
Q
|
| Validation methods: |
RNase R Treatment; Actinomycin D / DRB Stability Assay; RT-qPCR; Clinical Sample Validation; Nuclear-Cytoplasmic Fractionation; Transfection; CCK8; Colony Formation Assay; Transwell Assay; Western Blot; Bioinformatics Analysis; Luciferase Reporter Assay; RNA Pull-Down; In Vivo Animal Model |
| Clinical significance: |
circKLHL24 is proposed as an effective biomarker for breast cancer and the circKLHL24/miR-1204/ALX4 network as a promising strategy for cancer treatment. |
| Description: |
circKLHL24 is downregulated in breast cancer tissues and cell lines. Its overexpression inhibits breast cancer cell viability, proliferation, migration, invasion, glycolysis, and xenograft tumor growth. Mechanistically, circKLHL24 sponges miR-1204 to increase ALX4 expression, forming a circKLHL24/miR-1204/ALX4 tumor-suppressive regulatory network. |
| Confidence score: |
0.8119 |